{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T01:34:50Z","timestamp":1787362490351,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10549-023-07158-w","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T14:02:26Z","timestamp":1698328946000},"page":"523-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch setting"],"prefix":"10.1007","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-800X","authenticated-orcid":false,"given":"Kay","family":"Schreuder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Bult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babet","family":"Stroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linetta B.","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhod\u00e9 M.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enja J.","family":"Bantema-Joppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije J.","family":"Hoornweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"7158_CR1","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.ejca.2010.06.119","volume":"46","author":"M Rosselli Del Turco","year":"2010","unstructured":"Rosselli Del Turco M, Ponti A, Bick U, Biganzoli, L et al (2010) Quality indicators in breast cancer care. Eur J Cancer 46:2344\u20132356. https:\/\/doi.org\/10.1016\/j.ejca.2010.06.119","journal-title":"Eur J Cancer"},{"key":"7158_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-0009.2005.00397.x","volume":"83","author":"A Donabedian","year":"2005","unstructured":"Donabedian A (2005) Evaluating the quality of medical care. Milbank Q 83:691\u2013729. https:\/\/doi.org\/10.1111\/j.1468-0009.2005.00397.x","journal-title":"Milbank Q"},{"key":"7158_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.breast.2020.02.003","volume":"51","author":"L Biganzoli","year":"2020","unstructured":"Biganzoli L, CardosoBeishon FM et al (2020) The requirements of a specialist breast centre. The Breast 51:65\u201384. https:\/\/doi.org\/10.1016\/j.breast.2020.02.003","journal-title":"The Breast"},{"key":"7158_CR4","unstructured":"The European Commission's science and knowledge service, JRC, https:\/\/ec.europa.eu\/jrc\/en"},{"key":"7158_CR5","unstructured":"European Commission Initiative on Breast Cancer. Development of the scheme. https:\/\/healthcare-quality.jrc.ec.europa.eu\/ecibc\/methodologies\/quality-assurance#inline-nav-2. Accessed October 10, 2022"},{"key":"7158_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejca.2016.10.023","volume":"72","author":"F Cardoso","year":"2017","unstructured":"Cardoso F, Cataliotti L, Costac A et al (2017) European Breast Cancer Conference manifesto on breast centres\/units. Eur J Cancer 72:244\u2013250. https:\/\/doi.org\/10.1016\/j.ejca.2016.10.023","journal-title":"Eur J Cancer"},{"key":"7158_CR7","unstructured":"Netherlands comprehensive cancer organization. IKNL and the NCR. www.iknl.nl\/en. Accessed October 18, 2022"},{"key":"7158_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/intqhc\/mzg081","volume":"15","author":"J Mainz","year":"2003","unstructured":"Mainz J (2003) Defining and classifying clinical indicators for quality improvement. Int J Quality Health Care 15:523\u2013530. https:\/\/doi.org\/10.1093\/intqhc\/mzg081","journal-title":"Int J Quality Health Care"},{"key":"7158_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/bmjqs.2010.046334","volume":"20","author":"D Neuhauser","year":"2011","unstructured":"Neuhauser D, Provost L, Bergman B (2011) The meaning of variation to healthcare managers, clinical and health-services researchers, and individual patients. BMJ Qual Saf 20:36\u201340. https:\/\/doi.org\/10.1136\/bmjqs.2010.046334","journal-title":"BMJ Qual Saf"},{"key":"7158_CR10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jval.2020.05.011","volume":"23","author":"EL Vos","year":"2020","unstructured":"Vos EL, Koppert LB, Jager A, Vrancken Peeters M, Siesling S, Lingsma HF (2020) From multiple quality indicators of breast cancer care toward hospital variation of a summary measure. Value Health 23:1200\u20131209. https:\/\/doi.org\/10.1016\/j.jval.2020.05.011","journal-title":"Value Health"},{"key":"7158_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jval.2019.12.014","volume":"23","author":"EL Vos","year":"2020","unstructured":"Vos EL, Lingsma HF, Jager A et al (2020) Effect of case-mix and random variation on breast cancer care quality indicators and their rankability. Value Health 23:1191\u20131199. https:\/\/doi.org\/10.1016\/j.jval.2019.12.014","journal-title":"Value Health"},{"key":"7158_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jso.24516","volume":"115","author":"AC van Bommel","year":"2017","unstructured":"van Bommel AC, Spronk PE, Peeters Vrancken et al (2017) NABON Breast Cancer Audit, Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: the National NABON Breast Cancer Audit. J Surg Oncol 115:243\u2013249. https:\/\/doi.org\/10.1002\/jso.24516","journal-title":"J Surg Oncol"},{"key":"7158_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ejca.2017.01.017","volume":"75","author":"MJ Duffy","year":"2017","unstructured":"Duffy MJ, Harbeck N, Nap M, Nicolini A, Senkus E, Cardoso F (2017) Clinical use of biomarkers in breast cancer: updated guidelines from the European Group on Tumor Markers (EGTM). Eur J Cancer 75:284\u2013298. https:\/\/doi.org\/10.1016\/j.ejca.2017.01.017","journal-title":"Eur J Cancer"},{"key":"7158_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12885-019-5292-2","volume":"19","author":"F Ebner","year":"2019","unstructured":"Ebner F, W\u00f6ckel A, Schwentner L et al (2019) Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? BMC Cancer 19:90. https:\/\/doi.org\/10.1186\/s12885-019-5292-2","journal-title":"BMC Cancer"},{"key":"7158_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/tbj.13376","volume":"25","author":"K Schreuder","year":"2019","unstructured":"Schreuder K, Middelburg JG, Aarts MJ et al (2019) An actualised population-based study on the use of radiotherapy in breast cancer patients in the Netherlands. Breast J 25:942\u2013947. https:\/\/doi.org\/10.1111\/tbj.13376","journal-title":"Breast J"},{"key":"7158_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jjco\/hys052","volume":"42","author":"N Duraker","year":"2012","unstructured":"Duraker N, Demir D, Bati B et al (2012) Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1\u20132 tumor and 1\u20133 axillary lymph node(s) metastasis. Jpn J Clin Oncol 42:601\u2013608. https:\/\/doi.org\/10.1093\/jjco\/hys052","journal-title":"Jpn J Clin Oncol"},{"key":"7158_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nrclinonc.2014.95","volume":"11","author":"R Orecchia","year":"2014","unstructured":"Orecchia R (2014) Breast cancer: post-mastectomy radiotherapy reduces recurrence and mortality. Nat Rev Clin Oncol 11:382\u2013384. https:\/\/doi.org\/10.1038\/nrclinonc.2014.95","journal-title":"Nat Rev Clin Oncol"},{"key":"7158_CR18","doi-asserted-by":"publisher","unstructured":"EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al. (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 21:2127\u20132135. https:\/\/doi.org\/10.1016\/S0140-6736(14)60488-8","DOI":"10.1016\/S0140-6736(14)60488-8"},{"key":"7158_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.breast.2017.05.011","volume":"34","author":"K Schreuder","year":"2017","unstructured":"Schreuder K, van Bommel ACM, de Ligt KM et al (2017) Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands. The Breast 34:96\u2013102. https:\/\/doi.org\/10.1016\/j.breast.2017.05.011","journal-title":"The Breast"},{"key":"7158_CR20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.breast.2005.08.010","volume":"14","author":"M Kaufmann","year":"2005","unstructured":"Kaufmann M, von Minckwitz G, Rody A (2005) Preoperative (neoadjuvant) systemic treatment of breast cancer. Breast 14:576\u2013581. https:\/\/doi.org\/10.1016\/j.breast.2005.08.010","journal-title":"Breast"},{"key":"7158_CR21","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.3390\/ijerph16244970","volume":"16","author":"ET Ng","year":"2019","unstructured":"Ng ET, Ang RZ, Tran BX et al (2019) Comparing quality of life in breast cancer patients who underwent mastectomy versus breast-conserving surgery: a meta-analysis. Int J Environ Res Public Health 16:4970. https:\/\/doi.org\/10.3390\/ijerph16244970","journal-title":"Int J Environ Res Public Health"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07158-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T11:19:52Z","timestamp":1706008792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07158-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["7158"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07158-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"According to the Central Committee on Research involving Human Subjects (CCMO), this type of study does not require approval from an ethics committee in the Netherlands. This study was approved by the Privacy Review Board of the Netherlands Cancer Registry.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}